Harvard Bioscience (HBIO) Change in Inventory (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Change in Inventory of $1.5 million for Q1 2026, up 329.85% year-over-year from $358263.9 in Q1 2025, and up 332.28% quarter-over-quarter from -$663000.0 in Q4 2025.
Harvard Bioscience (HBIO) Change in Inventory (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Change in Inventory for 17 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory rose 329.85% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at -$737000.0 (up 39.74% YoY), while the FY2025 annual figure was -$2.9 million, down 4704.69% from the prior year.
- Change in Inventory improved to $1.5 million in Q1 2026 per HBIO's latest filing, from -$663000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $1.5 million in Q1 2026 and bottomed at -$2.4 million in Q4 2024.
- Historically, Change in Inventory has averaged -$183470.6 across 5 years, with a median of -$581000.0 in 2022.
- Annual changes were most pronounced in 2022 — Change in Inventory sank 253.61% — and 2026, when it soared 329.85%.
- Harvard Bioscience's Change in Inventory stood at -$581000.0 in 2022, then tumbled by 132.53% to -$1.4 million in 2023, then tumbled by 74.09% to -$2.4 million in 2024, then jumped by 71.81% to -$663000.0 in 2025, then soared by 332.28% to $1.5 million in 2026.
- Business Quant data shows HBIO's Change in Inventory at $1.5 million in Q1 2026, -$663000.0 in Q4 2025, and -$637000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 248.00 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 33.87 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 74.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -50.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -59.00 Mn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | 184,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 184,000.00 |
| Jun 30, 2026 | 184,000.00 |
| Mar 31, 2026 | 1.54 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | -663,000.00 |
| Dec 31, 2025 | -663,000.00 |
| Sep 30, 2025 | -637,000.00 |
| Sep 30, 2025 | -637,000.00 |
| Jun 30, 2025 | -977,000.00 |
| Jun 30, 2025 | -977,000.00 |
| Mar 31, 2025 | -670,000.00 |
| Mar 31, 2025 | -670,000.00 |
| Dec 31, 2024 | -2.35 Mn |
| Dec 31, 2024 | -2.35 Mn |
| Sep 30, 2024 | 668,000.00 |
| Sep 30, 2024 | 668,000.00 |
| Jun 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 617,000.00 |
| Mar 31, 2024 | 617,000.00 |